Cargando…
HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy
Human endogenous retroviruses (HERVs) represent 8% of the human genome. The expression of HERVs and their immune impact have not been extensively studied in Acute Myeloid Leukemia (AML). In this study, we used a reference of 14 968 HERV functional units to provide a thorough analysis of HERV express...
Autores principales: | Alcazer, Vincent, Bonaventura, Paola, Tonon, Laurie, Michel, Emilie, Mutez, Virginie, Fabres, Clémentine, Chuvin, Nicolas, Boulos, Rasha, Estornes, Yann, Maguer‐Satta, Véronique, Geistlich, Kevin, Viari, Alain, Metzeler, Klaus H., Hiddemann, Wolfgang, Batch, Aarif M. N., Herold, Tobias, Caux, Christophe, Depil, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540360/ https://www.ncbi.nlm.nih.gov/pubmed/35759575 http://dx.doi.org/10.1002/ajh.26647 |
Ejemplares similares
-
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
por: Bonaventura, Paola, et al.
Publicado: (2022) -
Human Endogenous Retroviruses (HERVs): Shaping the Innate Immune Response in Cancers
por: Alcazer, Vincent, et al.
Publicado: (2020) -
Cancer vaccines: what’s next?
por: Depil, Stéphane, et al.
Publicado: (2019) -
Cold Tumors: A Therapeutic Challenge for Immunotherapy
por: Bonaventura, Paola, et al.
Publicado: (2019) -
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
por: Baulu, Estelle, et al.
Publicado: (2023)